Novabay Pharmaceuticals Inc.
13F holders, Q3 2024 (September 30)13holders +5
5new positions
0sold out
$0.69avg. 13F price*
At the end of Q3 2024, 13 institutions reported holding Novabay Pharmaceuticals Inc. in their 13F filings, up 5 from Q2 2024. 5 opened new positions and 0 sold out. The largest holders were C2C Wealth Management, LLC ($31K), Geode Capital Management, LLC ($18K) and UBS Group AG ($15K).
- Company
- Novabay Pharmaceuticals Inc.
- CUSIP
- 66987P409
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $69K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 114,469 shares bought, net +114,469 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| C2C Wealth Management, LLC | 0.03% | New | 42,948 | $31K |
| Geode Capital Management, LLC | 0.00% | New | 26,337 | $18K |
| UBS Group AG | 0.00% | Add +158.2% | 21,062 | $15K |
| Virtu Financial LLC | 0.00% | New | 19,590 | $13K |
| Warberg Asset Management LLC | 0.03% | New | 10,000 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +66.4% | 5,481 | $4K |
| Morgan Stanley | 0.00% | Add +16666.7% | 503 | $347 |
| Bank of America Corp. | 0.00% | No change | 42 | $29 |
| Blue Trust, Inc. | 0.00% | New | 2 | $4 |
| Nvwm, LLC | 0.00% | No change | 3 | $2 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1 | $1 |
| Addison Advisors LLC | 0.00% | No change | 1 | $1 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is NOVABAY PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Novabay Pharmaceuticals Inc. the manager owns.